We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

7 hedge funds and large institutions have $845K invested in Alexion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 693 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

99% less funds holding

Funds holding: 707 → 7 (-700)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 693

100% less funds holding in top 10

Funds holding in top 10: 77 → 0 (-77)

100% less capital invested

Capital invested by funds: $38.8B → $845K (-$38.8B)

Holders
7
Holders Change
-700
Holders Change %
-99.01%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-77
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
693
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NICM
Neo Ivy Capital Management
New York
+$475K
2
TAIM
TD Ameritrade Investment Management
Nebraska
+$131K
3
RG
Retirement Group
California
+$9.37K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74B
2
BlackRock
BlackRock
New York
-$3.21B
3
State Street
State Street
Massachusetts
-$1.84B
4
FCM
Farallon Capital Management
California
-$1.42B
5
HI
HBK Investments
Texas
-$1.21B
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
– -$359M -1,951,561 Closed
Franklin Resources
27
Franklin Resources
California
– -$349M -1,902,026 Closed
Bank of New York Mellon
28
Bank of New York Mellon
New York
– -$335M -1,826,157 Closed
Legal & General Group
29
Legal & General Group
United Kingdom
– -$323M -1,758,060 Closed
JP Morgan Chase
30
JP Morgan Chase
New York
– -$321M -1,748,795 Closed
CS
31
Credit Suisse
Switzerland
– -$321M -1,744,843 Closed
Morgan Stanley
32
Morgan Stanley
New York
– -$317M -1,725,693 Closed
LSV Asset Management
33
LSV Asset Management
Illinois
– -$314M -1,710,802 Closed
PAM
34
PSquared Asset Management
Switzerland
– -$282M -1,536,316 Closed
Canada Pension Plan Investment Board
35
Canada Pension Plan Investment Board
Ontario, Canada
– -$276M -1,500,325 Closed
TCA
36
Taconic Capital Advisors
New York
– -$272M -1,481,000 Closed
Bank of America
37
Bank of America
North Carolina
– -$263M -1,429,070 Closed
Assenagon Asset Management
38
Assenagon Asset Management
Luxembourg
– -$262M -1,426,193 Closed
WCMNY
39
Westchester Capital Management (New York)
New York
– -$255M -1,388,701 Closed
Swedbank
40
Swedbank
Sweden
– -$249M -1,355,389 Closed
N
41
Natixis
France
– -$246M -1,339,811 Closed
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
– -$241M -1,314,023 Closed
OPU
43
Omni Partners US
California
– -$326M -1,283,115 Closed
AllianceBernstein
44
AllianceBernstein
Tennessee
– -$230M -1,254,045 Closed
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
– -$228M -1,241,928 Closed
AAM
46
Alpine Associates Management
Florida
– -$224M -1,219,200 Closed
GCL
47
Glazer Capital LLC
New York
– -$221M -1,205,390 Closed
MF
48
Magnetar Financial
Illinois
– -$205K -1,114,010 Closed
Bank of Nova Scotia
49
Bank of Nova Scotia
Ontario, Canada
– -$203M -1,104,245 Closed
Charles Schwab
50
Charles Schwab
California
– -$195M -1,061,176 Closed
1
2
3 4 5

ALXN Hedge Fund Activity: Q3 2021 in Review

7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q3 2021, worth a combined $845K — down 100% from $38.8B a quarter earlier.

Sellers outnumbered buyers: 693 funds closed out of ALXN and 1 opened new positions — a net loss of 692 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Neo Ivy Capital Management, opening a new position worth an estimated $475K. The largest seller was Vanguard Group, exiting entirely with an estimated $3.74B sold.

  • 7 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q3 2021, down from 707 in Q2 2021.
  • Funds reported $845K of Alexion Pharmaceuticals stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Alexion Pharmaceuticals positions in Q3 2021 and 693 closed out, a net change of -692 holders.
  • The largest Alexion Pharmaceuticals buyer in Q3 2021 was Neo Ivy Capital Management, an estimated $475K added.
  • The largest Alexion Pharmaceuticals seller in Q3 2021 was Vanguard Group, an estimated $3.74B sold.

Based on aggregated 13F filings for Q3 2021.